COVID-19 Updates

With the shared concern over coronavirus disease 2019 (COVID-19), ACTRIMS strives to keep individuals with MS informed, safe and supported.  As the pandemic continues to change, so do the ways in which we live our lives.

COViMS (COVID-19 Infections in MS & Related Diseases) is a joint effort of the National MS Society and the Consortium of MS Centers to capture information on outcomes of people with MS and other CNS demyelinating diseases (Neuromyelitis Optica, or MOG antibody disease) who have developed COVID-19. We hope to capture the majority of all North American cases of COVID-19 in people with MS and other CNS demyelinating diseases.  We will rapidly define the impact of COVID-19 on patients with MS and other CNS demyelinating diseases and how factors such as age, comorbidities, and treatments are associated with COVID-19 outcomes.

Growing data indicates there are neurological manifestations of COVID-19 infection. In the Neurological Manifestations of COVID-19 Infection episode of the Neuro Pathways podcast series, Jeffrey Cohen, MD, discusses the mounting evidence and the neurological manifestations presenting in COVID-19-positive patients. This episode is available on the Consult QD website and all podcast platforms (e.g. iTunes, Google Play, Spotify, iHeart Radio, etc.). 

Reference the below resources for more COVID-19 information and tips to ensure your safety and safety of those around you. 

• General guidance from the World Health Organization (WHO), the Centers for Disease Control (CDC)
• The MS International Federation offers COVID-19 advice for people with MS
• What you need to know about COVID-19 from the National Multiple Sclerosis Society
• Find out your COVID-19 Risk from the Cleveland Clinic
• National MS Society and CMSC webinar about MS and COVID-19, featuring Anne Cross, MD, and Avindra Nath, MD
• National MS Society COVID-19 Vaccine Guidance for People Living with MS
• MS Society of Canada COVID-19 Vaccine Guidance for People Living with MS